The Board of Directors of the IKCC seeks an additional Board General Director to join the Board in 2025. This role is a full board position with no initial portfolio responsibilities.

This role involves participating in board meetings, providing input on key decisions, and contributing expertise or guidance on matters relevant to the organisation’s mission and objectives.

General Director members play a critical role on the Board of Directors. Having no permanent set of duties, they are available to take on tasks as the Board’s strategy evolves or urgent matters become apparent.

The importance of a General Director lies in their ability to offer broad perspectives and diverse insights to the Board. They bring a wealth of knowledge, experience, and skills from various backgrounds (see below), which can enrich discussions, enhance decision-making processes, and ensure the Board considers a wide range of viewpoints whilst working to implement the vision and goals set out in the 5-Year Strategic Plan for the IKCC.

Skills and Experience Required
The IKCC Board welcomes expressions of interest from all interested candidates who share our passion to reduce the global burden of kidney cancers. Candidates should have prior non-profit Board experience, ideally in health-related non-profit organisations at the national, regional, or international level.

Preferred skillsets may include any of the following:

  • Health policy experience, including global cancer policy, national cancer plans, advocacy for health policy change at the national, regional, or international level
  • Experience working in and across health systems in Low- and Middle-Income Countries (LMIC)
  • Business development and global philanthropy expertise
  • Fundraising (oversight), including stewardship and global campaigns to support fundraising efforts of non-profit organisations such as IKCC partner (affiliate) organisations
  • Digital technology leadership to support global outreach
  • Understanding of cancer research in general, including research of kidney cancers and clinical trials with perspectives on the unmet needs of patients and carers globally.

Length of Term: 3 years, renewable once.